--- schema_version: "secwatch.filing_event.v1" accession: "0001493152-26-021330" form_type: "8-K/A" ticker: "CHRN" cik: "0001549084" company_name: "EKSO BIONICS HOLDINGS, INC." filed_at: "2026-05-05T23:59:59+00:00" generated_at: "2026-05-14T23:21:16.396961+00:00" event_type: "m_and_a" sentiment: "neutral" materiality_score: 0.95 calibrated_materiality_score: 0.95 confidence: "high" source: SEC EDGAR --- # Ekso Bionics completes reverse merger with Applied Digital subsidiary; renames to ChronoScale Corp. ## Summary - Applied Parent & Contributor now hold ~97% of outstanding shares; legacy Ekso holders retain ~3%. - Company issued 138,216,820 new shares to Contributor for 100% of Cloud; post-merger shares outstanding 143,093,381. - Applied Parent invested $15.75M via PIPE at $12.01/share, receiving 1,311,407 shares. - Board reconstituted with 4 APLD designees (Wes Cummins as Chairman); ticker changes to 'CHRN' on Nasdaq. - Fiscal year end changed to May 31; authorized common shares increased to 290M. ## SEC filing metadata - accession: 0001493152-26-021330 - form_type: 8-K/A - ticker: CHRN - cik: 0001549084 - company_name: EKSO BIONICS HOLDINGS, INC. - filed_at: 2026-05-05T23:59:59+00:00 - event_type: m_and_a - sentiment: neutral - materiality_score: 0.95 - calibrated_materiality_score: 0.95 - confidence: high - sec_items: 1.01, 2.01, 2.02, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/form8-ka.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001493152-26-021330 - JSON: https://secwatch.observer/filing/0001493152-26-021330.json - Plain text: https://secwatch.observer/filing/0001493152-26-021330.txt ## Source-grounded claims - claim_id: 60237ad5dfb38cd130991ec8d83a6f4d58c166e9 claim: EKSO BIONICS HOLDINGS, INC. dismissed WithumSmith+Brown, PC as its auditor. evidence_excerpt: On May 5, 2026, the audit committee of the Board approved (i) the termination of the engagement of WithumSmith+Brown, PC evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm - claim_id: b8d85d177cb7e820c51af5bbda0eb81920f5a0c5 claim: EKSO BIONICS HOLDINGS, INC. engaged CBIZ CPAs P.C. as its auditor. evidence_excerpt: ay 5, 2026, the audit committee of the Board approved (i) the termination of the engagement of WithumSmith+Brown, PC (“Withum”), the Company’s independent registered public accounting firm prior to the Business Combination, and (ii) the engagement of CBIZ evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm - claim_id: 086f8cb203 claim: Ying Cenly Chen was appointed as Director at EKSO BIONICS HOLDINGS, INC.. evidence_excerpt: the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm - claim_id: 0ee9dfcd15 claim: Douglas Miller was appointed as Director at EKSO BIONICS HOLDINGS, INC.. evidence_excerpt: the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm - claim_id: 22e90ad815 claim: William M. Clancy was appointed as Director at EKSO BIONICS HOLDINGS, INC.. evidence_excerpt: the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm - claim_id: 34350002f6 claim: Scott G. Davis was appointed as Director at EKSO BIONICS HOLDINGS, INC.. evidence_excerpt: the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm - claim_id: 38be120717 claim: Richard Nottenburg was appointed as Director at EKSO BIONICS HOLDINGS, INC.. evidence_excerpt: the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm - claim_id: 645f2c193f claim: Mary Ann Cloyd resigned as Director at EKSO BIONICS HOLDINGS, INC.. evidence_excerpt: the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm - claim_id: 6d9252b185 claim: Ella Benson was appointed as Director at EKSO BIONICS HOLDINGS, INC.. evidence_excerpt: the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm - claim_id: 7612809ae5 claim: Charles Li resigned as Director at EKSO BIONICS HOLDINGS, INC.. evidence_excerpt: the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm - claim_id: 781143cc0b claim: Corinna Lathan resigned as Director at EKSO BIONICS HOLDINGS, INC.. evidence_excerpt: the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm - claim_id: a705d750bb claim: Deborah Lafer Scher resigned as Director at EKSO BIONICS HOLDINGS, INC.. evidence_excerpt: the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm - claim_id: cbdef21e92 claim: Wes Cummins was appointed as Chairman of the Board at EKSO BIONICS HOLDINGS, INC.. evidence_excerpt: the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm - claim_id: 15ab66376a3871ceae050ad250c5c9041ba42ca7 claim: EKSO BIONICS HOLDINGS, INC.: Second Amended and Restated Articles of Incorporation filed with Nevada Secretary of State, effective May 5, 2026, including name change to ChronoScale Corporation, increase in authorized common shares from 141,428,571 to 290,000,000, and other changes (effective 2026-05-05). evidence_excerpt: on May 1, 2026, the Company filed the Second Amended and Restated Articles of Incorporation (the “A&R Articles”) with the Secretary of State of the State of Nevada with a delayed effective date and time of 3:00 a.m. (Eastern Time) on May 5, 2026. evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm - claim_id: 4ee61d6d862970aeca7c200bbf8fbe29c4d24858 claim: EKSO BIONICS HOLDINGS, INC.: Changed fiscal year end from December 31 to May 31. evidence_excerpt: In connection with the Business Combination, as of the Closing Date, the Company changed its fiscal year end from December 31 to May 31. evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm - claim_id: f0ec14f6d93210a1db505ebcb0e7f84be8987559 claim: EKSO BIONICS HOLDINGS, INC.: Second Amended and Restated Bylaws adopted effective upon Closing on May 5, 2026 (effective 2026-05-05). evidence_excerpt: Upon Closing and effective upon Closing, the Company adopted the Second Amended and Restated Bylaws (the “A&R Bylaws” and, together with the A&R Articles, the “Amended Charter Documents”). evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm - claim_id: 4249547e4d2bc4a30df87d42f6dba35cef8fb35e claim: EKSO BIONICS HOLDINGS, INC. underwent a change of control involving Applied Digital Corporation (closed 2026-05-05). evidence_excerpt: On May 5, 2026 (the “Closing Date”), Ekso Bionics Holdings, Inc., a Nevada corporation (“Ekso” or the “Company”), consummated the previously announced business combination transaction (the “Business Combination”) contemplated by that certain Contribution and Exchange Agreement evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.